Physician profile
Krithika Ramadas
NPI 1710939715
$6,697.30
in general payments reported to CMS, 2019-2025
17 companies · $42.10 in 2025
The $42.10 reported for 2025 was less than what a typical Allergy provider received nationally (typical 2025 total: $1,129).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,683 · 2020: $2,066 · 2021: $294 · 2022: $268 · 2023: $93.28 · 2024: $252 · 2025: $42.10.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $387.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $386.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optinose US, INC. | $3,679.83 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $2,223.89 | 2019-2024 | Dupixent |
| Glaxosmithkline, LLC. | $355.95 | 2020-2024 | Nucala, Trelegy Ellipta |
| Astrazeneca Pharmaceuticals LP | $122.21 | 2020-2025 | Fasenra, Tezspire |
| Boehringer Ingelheim Pharmaceuticals, INC. | $67.29 | 2020-2021 | |
| Covis Pharma Gmbh | $34.88 | 2021 | |
| Genentech USA, INC. | $29.22 | 2024 | Xolair |
| Biocryst US Sales Co., LLC | $24.51 | 2023 | Orladeyo |
| Blueprint Medicines Corporation | $21.74 | 2024 | Ayvakit |
| Kaleo, INC. | $20.67 | 2022 | |
| Phadia US INC. | $19.89 | 2020 | |
| Csl Behring | $19.75 | 2020 | |
| Amgen INC. | $18.27 | 2022 | |
| Ars Pharmaceuticals Operations, INC. | $16.56 | 2025 | Neffy |
| Takeda Pharmaceuticals U.S.A., INC. | $15.66 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $13.72 | 2019 | |
| Novartis Pharmaceuticals Corporation | $13.26 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Krithika Ramadas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.